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Survey of pharmacist-managed primary care
clinics using healthcare failure mode
and effect analysis
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Zachary A. WEBER, Jessica E. WILHOITE.
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ABSTRACT*
Objectives: The primary objective was to expand
upon results of a previously piloted patient
perception survey with Healthcare Failure Mode and
Effect Analysis (HFMEA), to identify areas within
pharmacist-managed clinics needing improvement.
Methods: The survey was adapted for use in
pharmacist-managed clinics. Patients completed the
survey following regularly scheduled pharmacist
appointments. Data were analyzed with a method
adapted from HFMEA. Product scores could range
from five to 25. A product of five indicates that
pharmacists are doing a good job on the items that
patients place the most value on, while a product
score of 25 indicates that pharmacists are doing a
poor job. A score greater than or equal to ten was
used to identify areas for improvement.
Results: Seventy-one patients completed surveys.
Thirteen components were assessed and no item
achieved a mean product greater than or equal to
ten. The survey item with the highest mean product
pertained to discussion of potential medication side
effects (mean: 7.06; interquartile range: 5-10).
Analysis of each survey item found that all survey
items had multiple individual responses that
provided a product score of greater than or equal to
ten. The survey items most frequently listed in the
overall population as being most valued were “Told
you the name of each of your medicines and what
they are used for”, “Answered your questions fully,”
and “Explained what your medicines do”.
Conclusions: Educational components provided
during pharmacist-managed clinic appointments are
*
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aligned with patients’ needs and are successfully
incorporating the components that patients value
highly in a patient-healthcare provider interaction.
The HFMEA model can be an important teaching
tool to identify specific processes in need of
improvement and to help enhance pharmacists’
self-efficacy, which may further improve patient
care.
Keywords: Pharmaceutical Services; Delivery of
Health Care; Systems Analysis; Total Quality
Management; United States

ESTUDIO DE CONSULTAS DE ATENCIÓN
PRIMARIA GESTIONADAS POR
FARMACÉUTICOS USANDO EL ANÁLISIS
DE MODOS Y EFECTOS DE FALLOS EN
SALUD
RESUMEN

Objetivos: El objetivo primario fue profundizar
sobre los resultados de un cuestionario pre-pilotado
de percepciones de los pacientes con el análisis de
modos y efectos de fallos en salud (HFMEA) para
identificar áreas en las que las consultas de
farmacéuticas necesitan mejorar.
Métodos: El cuestionario fue adaptado para su uso
en consultas farmacéuticas. Los pacientes cubrieron
el cuestionario después de las citas farmacéuticas
acordadas. Los datos se analizaron usando un
método adaptado del HFMEA. Las puntuaciones de
producto podían oscilar de 5 a 25. Un producto de 5
indicaba que el farmacéutico estaba realizando un
buen trabajo en los ítems que el paciente valorizaba
más, mientras que una puntuación de 25 indicaba
que el farmacéutico estaba haciendo un mal trabajo.
Se utilizaron las puntuaciones de 10 o más para
identificar áreas de mejoría.
Resultados: 71 pacientes completaron
cuestionarios. Se evaluaron 33 componentes y
ningún ítem alcanzó un producto medio mayor o
igual a 10. El punto de la encuesta que alcanzó la
media más alta trataba de la discusión de los
potenciales efectos secundarios de la medicación
(media: 7.06; rango intercuartilico: 5-10). El
análisis de cada ítem del cuestionario encontró que
todos los ítems tenían varias respuestas individuales
que proporcionaban una puntuación igual o mayor
de 10. Los ítems más frecuentemente considerados
por la población total como siendo los más
valorados fueron “le dijo el nombre de todos sus
medicamentos y para que se usan”, “respondió
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completamente sus preguntas” y “explico lo que
hacen los medicamentos”.
Conclusiones: Los componentes educativos
proporcionados en las visitas a las consultas
farmacéuticas se alinean con las necesidades de los
pacientes e incorporan con éxito los componentes
que los pacientes valoran más en la interacción
paciente-profesional de la salud. El modelo
HFMEA puede ser una importante herramienta
educativa para identificar procesos específicos que
necesitan mejorar y para ayudar a aumentar la autoeficacia de los farmacéuticos, lo que podrá en el
futuro mejorar la atención a pacientes.
Palabras clave: Servicios Farmacéuticos;
Prestación de Atención de Salud; Análisis de
Sistemas; Gestión Total de la Calidad; Estados
Unidos

INTRODUCTION
The recognition of pharmacists as healthcare
providers in recent Medicare legislation is an
important step in the expansion and acceptance of
1
clinical pharmacy services. It has been widely
accepted within pharmacy organizations that
pharmaceutical care should be the focus of all
pharmacists.2 This emphasis on pharmaceutical
care and pharmacist-patient interaction is also
widely noted within regulations enacted by
3,4
Congress. There are many documented benefits
5of pharmacist-managed care on disease outcomes
9
, but information related to patient perceptions of
pharmacist-managed care is lacking. As previously
demonstrated by Gonzalvo and colleagues, there
are consistent and emerging themes related to
patient perceptions of pharmacist-managed care10,
but there is limited guidance to help identify whether
process improvement is needed in the clinical
pharmacist-patient interaction. To compensate for
the sparse amount of qualitative data relating to
pharmacist-managed care, survey data have
routinely been collected to determine patient
11,12
satisfaction and perceptions of care.
Recognizing the subjectivity of survey results,
Healthcare Failure Mode and Effect Analysis
(HFMEA) is a method that has been successfully
implemented to add weight to the importance of
survey responses by assigning numerical value.13
Traditionally, HFMEA has been used to proactively
evaluate healthcare processes and identify areas
for improvement or to enhance an existing service.
Healthcare Failure Mode and Effect Analysis has
also been used to identify a cause and effect
relationship to reduce medication errors.14,15
HFMEA can provide a useful measure to improve
clinical pharmacy services by identifying areas with
the greatest impact based on what the patient
values as important.
As opportunities for pharmacists continue to grow,
those services offered must be evaluated to
determine if they are consistent with what is valued
by patients. The research noted by Knight and
Caudill focused on a pharmacotherapy clinic at one
Veterans Affairs Medical Center.13 This study builds

upon their previous work by using the HFMEA
model based on surveys of patients referred to the
clinical pharmacist for disease state management
across multiple pharmacist-managed clinics.
The primary objective of this multicenter study was
to expand upon the results of a previously piloted
patient perception survey with HFMEA13, to identify
areas within pharmacist-managed clinics that need
improvement based on patient perceptions.
METHODS
This study was conducted at six pharmacistmanaged clinics within the central Indiana region,
with data collection occurring over a six-week period
between January and June 2012. Pharmacistmanaged clinics were included based upon
similarities in clinic location (i.e.; urban setting) and
scope of clinical pharmacy services offered (i.e.;
collaborative practice agreements for chronic
disease management). Four of the six clinic sites
generate
patient
charges
for
pharmacist
appointments per their institution specific guidelines.
Approval was obtained from each site’s Institutional
Review Board (IRB), and to maintain patient
anonymity, no patient identifiers were recorded.
Survey Development
The survey utilized in this study was adapted with
permission from a previously published patient
perception survey and was adjusted for utilization in
participating pharmacist-managed clinics. The
survey was originally designed to measure patient
perceptions of the quality of education provided at a
13
single Veteran’s Affairs institution. For the current
study, the survey was expanded to incorporate a
variety of pharmacist-managed clinics at multiple
institutions across different health systems, to
identify common areas of the pharmacist-patient
interaction in need of improvement. Patients were
instructed to respond based on only the medications
and disease states managed by the pharmacist, not
all medications and disease states.
Survey Implementation
The 27-item survey (online supplementary material)
was distributed to six participating pharmacists for
use in their pharmacist-managed clinic. Patients are
referred to these pharmacist-managed clinics by
their physicians for education and medication
management. Each clinical pharmacist works
closely with their patients and providers through a
collaborative practice agreement to adjust
therapies, obtain and assess necessary monitoring
parameters, and help achieve desired therapeutic
outcomes. The disease states managed were
specific to each pharmacist-managed clinic and
included anticoagulation, diabetes, hyperlipidemia,
hypertension, smoking cessation, and general
pharmacotherapy clinics. Patients presenting for
routine follow-up in a participating pharmacistmanaged clinic were eligible for inclusion, while
patients under 18 years of age, had less than two
prior visits with the pharmacist, or who were unable
to read English were excluded from the study.
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Table 1. Patient Demographics
Average age in years (SD)
56 (12)
Gender*
Male
36 (50.7%)
Female
35 (49.3%)
Ethnicity*
Hispanic or Latino
1 (1.4%)
Not Hispanic or Latino
70 (98.6%)
Race**
American Indian/Alaska Native
3 (4%)
Asian
1 (1.4%)
Black/African American
26 (37.1%)
Native Hawaiian/Pacific Islander
0
White/Caucasian
40 (57.1%)
No. of past pharmacist-managed clinic
visits*
14 (34.1%)
2
21 (29.6%)
3-4
11 (15.5%)
5-7
13 (18.3%)
8-10
12 (16.9%)
>10
Prescription Drug coverage***
Institution specific
32 (47.8%)
Medicaid/Medicare
21 (31.3%)
Private
6 (9.0%)
Cash/no third party
7 (10.4%)
Total average no. of medications per
8.1 (5.3)
+
patient (SD)
Average no. of medications managed by
4.2 (3.6)
+
pharmacist per patient (SD)
Pharmacist-managed disease state*
Diabetes
34 (47.9%)
Warfarin (Coumadin) management
19 (26.7%)
High blood pressure
30 (42.2%)
Quitting smoking
3 (4.2%)
High cholesterol
42 (59.2%)
Other
3 (4.2%)****
Duration of pharmacist-managed
6.5 (7.4)
++
disease state in years (SD)
+
++
* n=71
** n=70 *** n=67 n=69
n=65
**** Total is greater than 100% due to patients having
multiple pharmacist-managed disease states

Eligible patients were recruited to participate
immediately following a regularly scheduled
appointment with the clinical pharmacist and were
asked to complete the survey in the waiting room or
empty exam room. Each patient was provided with
written instructions, and completed surveys were
given to reception staff within each clinic. The
surveys were administered over a six week period
to capture as many eligible patients as possible;
however, each institution utilized a different six
week period within the data collection period based
on participating pharmacists’ availability. Each
eligible patient completed one survey during the six
week study period, regardless of number of visits
with the pharmacist during that time. There was no
randomization or patient selection criteria other than
the exclusion criteria previously defined.

and easy identification of areas for improvement
based on numerical scores. For this analysis,
product scores could range from a score of five to
25, with a product value of five indicating that
pharmacists are doing a good job on the items that
patients place the most value on while a product
score of 25 would indicate that pharmacists are
doing a poor job on the items that patients feel are
most important. The specific steps used for
calculating the HFMEA scores have been published
previously13, and include scoring each survey
component to be assessed, then multiplying
corresponding components from sections 1 and 2 of
the survey to determine an overall product score for
that item. Traditionally, a product greater than onehalf of the highest score is used to indicate the need
for improvement when using a HFMEA method. To
maintain consistency with previously published
methods, a conservative final score greater than or
equal to 10 was used to identify areas for
improvement across the pharmacist-managed clinic
sites.
RESULTS
A total of 71 patients completed surveys during the
data collection period. Fifty percent of survey
respondents were male, with an average age of
56±12 years (Table 1). Of the 13 components
assessed, no item achieved a mean product of
greater than or equal to ten (Table 2). Survey item
4, “Described the possible side effects of each of
your medicines,” had the highest overall mean
product at 7.05. Analysis of each survey item found
that all survey items had multiple individual
responses that provided a product score of greater
than or equal to ten (Figure 1). When evaluating the
survey responses based on the specific disease
state managed by the pharmacist, the patients with
diabetes had the highest mean product for survey
item 4 with a product score of 7.5. This score was
lowest at 6.3 for patients seeing the clinical
pharmacist for management of warfarin therapy.
Survey item 5, “Provided information about your
medical problems and the benefits of treating them”,
had the second highest overall mean product score

Statistical Analysis
Data were analyzed with a method adapted from
that used in a HFMEA process and with standard
descriptive statistical methods, to examine quality
improvement results. The HFMEA is a prospective
assessment that provides a method for placing
weights on outcomes (i.e.: assigning a value to the
importance of various components of patient
education based on what the patient feels is most
important). This allows for results to be prioritized

Figure 1. Number of Individual responses with product
score ≥10 (n=71) *n=70; **n=68
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Table 2. Survey Results
Survey Item
1. Told you the name of each of your medicines and what they are used for
2. Explained what your medicines do
3. Instructed you on how you should take your medicines
4. Described the possible side effects of each of your medicines
5. Provided information about your medical problems and the benefits of treating them
6. Discussed goals of treatment for each of your medical problems
7. Talked to you about the next steps in managing your medical problems
8. Answered your questions fully
9. Discussed the resources available to help you with your medications
10. Spent plenty of time with you
11. Talked to you in a way you could easily understand
12. Treated you with respect and courtesy
13. Rating of your clinical pharmacy visits overall
* n=70; **n=68

at 6.31. The mean product score was highest
among patients seeing the pharmacist for
hyperlipidemia management (mean=6.5) and lowest
among patients seeing the pharmacist for warfarin
management (mean=5.9). The majority of the
remaining overall mean products were in the 5 to 6
point range.
The final non-demographic survey question asked
patients to list three items they most valued. Of the
53 patients that responded, those items listed most
often were “Told you the name of each of your
medicines and what they are used for”, “Answered
your questions fully”, and “Explained what your
medicines do”. The specific frequencies of response
by survey item can be found in Table 3. The six
items most frequently listed as being “most valued”
by patients all had a mean product <5.9. The
frequency of the most valued educational
components
was
compared
between
Males/Females
(Figure
2)
and
African
Americans/Caucasians (Figure 3). Males rated
survey items 8 and 11 as most valued more often
than females; females rated survey items 6, 7 and
10 as most valued more often than males. African
American participants rated survey items 4, 7, 10,
and 12 more often than Caucasian participants;
Caucasian participants more frequently rated survey
items 1, 3, and 6 compared with African American
participants.
DISCUSSION
The results obtained from this survey indicate that,
collectively, clinical pharmacists are performing at a
satisfactory level during each pharmacist-patient

Mean Product (IQ range)
n=71
5.79 (5-5)*
5.85 (5-5)*
5.83 (5-10)
7.06 (5-10)
6.31 (5-8)
6.01 (5-7)
6.07 (5-7)
5.63 (5-5)
6.35 (5-7)
5.69 (5-5)**
5.41 (5-5)
5.54 (5-5)
6.01 (5-5)

visit. No item achieved a product score high enough
to be flagged as needing improvement based on
HFMEA methods. Assessing the individual product
scores has highlighted areas on which to focus
future quality improvement efforts (i.e.: describing
the possible side effects of each of medicine).
Interestingly, these results, along with prior
13
results , found that the individual response most
commonly associated with a score of greater than
or equal to ten related to the discussion of potential
medication side effects. This may indicate that
pharmacists working in a pharmacist-managed
clinic feel it is more important to focus on overall
disease state management and perhaps assume
that the pharmacist dispensing the prescription will
educate the patient on the medication itself,
including the possible side effects. Additionally, side
effects may have been discussed when medication
was initiated, but not emphasized at each patient
visit if no medication changes were being made.
Pharmacists working in pharmacist-managed clinics
should develop ways to incorporate this educational
component into patient interactions.
When looking at the items frequently marked as
being the most valued by patients overall, the
product scores indicate that clinical pharmacists are
satisfying patients’ expectations across a variety of
pharmacist-managed clinic settings. However, when
looking at specific patient populations there are
some differences in what is valued most highly
during an appointment with a clinical pharmacist.
Male
participants
more
strongly
valued
communication in a way that could be easily
understood and that fully answered questions than
the female participants. The female participants

Table 3: Survey Responses Listed as 1 of 3 Most Valued Items
Survey Item
Told you the name of each of your medicines and what they are used for
Answered your questions fully
Explained what your medicines do
Treated you with respect and courtesy
Instructed you on how you should take your medicines
Talked to you in a way you could easily understand
Described the possible side effects of each of your medicines
Discussed goals of treatment for each of your medical problems
Provided information about your medical problems and the benefits of treating them
Talked to you about the next steps in managing your medical problems
Spent plenty of time with you
Discussed the resources available to help you with your medications
Rating of your clinical pharmacy visits overall
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n = 53
26
24
18
17
15
14
11
11
7
7
6
2
1

199

Vincent AH, Gonzalvo JD, Ramsey DC, Walton AM, Weber ZA, Wilhoite JE. Survey of pharmacist-managed primary
care clinics using healthcare failure mode and effect analysis. Pharmacy Practice 2013 Oct-Dec;11(4):196-202.

Figure 2. Survey responses listed as 1 of 3 most valued items (Males=27 / Females=26)

placed a higher value on discussing goals of
treatment and next steps of therapy, along with
spending plenty of time with the patient, than did the
male participants. Additionally, African American
participants more frequently ranked being treated
with respect and courtesy as a highly valued
appointment component than did Caucasian
participants, while Caucasian participants more
frequently ranked being told how to take their
medications. These differences among patient
populations illustrate the need for continued
awareness on the part of the clinician in a

pharmacist-managed clinic to ensure that each
patient is getting the most out of their individual
appointment by including components that are most
likely to be highly valued.
The results found in this study are consistent with
the previously published qualitative data on
pharmacist-patient interactions10,13 and support the
idea that disease state management by pharmacists
is a successful extension of care for chronic
diseases. Time constraints in primary care often
limit the services that can be provided by

Figure 3: Survey Responses Listed as 1 of 3 Most Valued Items (African American=18 / Caucasian=32)
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physicians.16,17 Not only are pharmacists able to
spend increased time with patients, but they are
also able to do it in a way that often exceeds patient
expectations of a patient-healthcare provider
interaction.
The use of HFMEA as a clinical process
improvement tool is a novel concept that can be
applied to all aspects of pharmaceutical care, not
just pharmacist-managed clinics. It is an important
tool that can help pharmacists to identify areas of
success as well as areas in need of improvement.
An additional benefit to using the HFMEA model is
its application as an important teaching tool to help
increase pharmacists’ self-efficacy, which may
further improve patient care.
While the survey used in this research was
originally designed to measure patient perceptions
of the quality of pharmacist education provided at a
single Veteran’s Affairs institution affiliated clinics
and found positive results in a small number of
13
patients , the current study expanded the survey
distribution to incorporate a variety of pharmacistmanaged clinics at multiple institutions across
different health systems, both Veteran’s Affairs and
non-Veteran’s Affairs. The low number of overall
participants in these studies highlights a larger
challenge presented to pharmacist-managed clinics,
the number of patients that do not keep their
scheduled appointments. The survey was offered to
each patient presenting to a pharmacist-managed
clinic appointment during a six week period, unless
they had already completed the survey. Patients
were allowed to decline participation, but the
majority of presenting patients chose to participate.
The overall number of scheduled appointments
during the six week survey period was significantly
higher than 71. Many of the participating
pharmacist-managed clinics had a patient no-show
rate of greater than 50 percent, leading to a smaller
than expected response rate.
The use of patient surveys as a research method is
subjective by nature and open to bias. Steps were
taken to minimize this bias by collecting data
anonymously, allowing patients to skip questions
they were not comfortable answering, and turning in
completed surveys to non-pharmacy clinic staff.
The study was not designed in a way to compare
results between patients receiving pharmacistmanaged care, and those not receiving pharmacistmanaged care. As a result, no statements regarding
the statistical significance of the data can be made;

however, this does not limit the clinical significance
or practical application of applying HFMEA results
to identify areas that need improvement during a
pharmacist-managed clinic appointment.
HFMEA scales are completely subjective in nature
and item values are determined by those
developing the scale. The authors attempted to limit
subjectivity by using the same scale and analysis
method that has been previously published.
Additionally, HFMEA is intended to be used as a
tool for process improvement. Each pharmacist’s
process may not be identical, introducing variables
into the analysis. However, the items assessed by
this survey are a part of each pharmacist-patient
encounter and are similar across a variety of
pharmacist-managed clinic settings. Based on the
largely positive results obtained in this study, as well
13
as the prior study by Knight and Caudill , it should
be considered whether or not the HFMEA tool is
sensitive enough to identify areas in need of
improvement in highly functioning pharmacistmanaged clinics. Further research involving both
newly developed and well established pharmacistmanaged clinics should be conducted to test the
sensitivity and validity of this HFMEA tool.
CONCLUSIONS
These results, combined with the results published
13
by Knight and Caudill , indicate that educational
components provided during pharmacist-managed
clinic appointments are aligned with patients’ needs
and clinic based pharmacists are able to
successfully incorporate the components that
patients value highly in a patient-healthcare provider
interaction. The HFMEA model can be utilized as an
important teaching tool to identify specific processes
in need of improvement and to help enhance
pharmacists’ self-efficacy, which may further
improve patient care.
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